NovaBay Pharmaceuticals, Inc. 4
4 · NovaBay Pharmaceuticals, Inc. · Filed Aug 2, 2016
Insider Transaction Report
Form 4
SIECZKAREK MARK M
Director
Transactions
- Award
Common Stock
2016-08-01$1.91/sh+261,780$500,000→ 715,498 total - Award
Warrant
2016-08-01+130,890→ 273,447 totalExercise: $1.91From: 2016-08-02Exp: 2026-08-02→ Common Stock (130,890 underlying)
Footnotes (2)
- [F1]Share acquisition pursuant to a securities purchase agreement, which is one of a series of securities purchase agreements that the company entered into for the sale of an aggregate 2,094,241 shares on July 31, 2016.
- [F2]Warrant acquisition pursuant to a securities purchase agreement, which is one of a series of securities purchase agreements that the company entered into for the sale of an aggregate 1,047,121 warrants on July 31, 2016.